Amwell 10-Q Details Q3 Loss of $11.4M, $180.8M Cash and Positive Operating Cash Flow Trend
AMWL has more than doubled off its 52-week low of $3.71.
Summary
Amwell's Q3 10-Q shows revenue of $49.0 million, a net loss of $11.4 million, and $180.8 million of cash with no debt; nine-month operating cash burn narrowed to $1.9 million from $48.6 million.
Key Events · Earnings and Guidance · AMWL
-
Q3 Revenue Falls 13% to $49.0M
Revenue was $48,991K versus $56,286K a year earlier, with subscription revenue down $7.0M on timing with strategic customers and visits down to 760,000 from 1,090,000.
-
Net Loss Widens to $11.4M
Net loss attributable to American Well was $11,361K, or $0.67 per share, versus $32,378K a year earlier; the sequential comparison is worse than Q2's $9.6M loss.
-
Cash Burn Narrows Sharply
Nine-month operating cash use was $1,934K versus $48,598K in 2025, leaving $180,786K of cash and no debt, consistent with the Q4 positive operating cash flow target.
-
Cost Cuts Drive the Improvement
Headcount fell 14% in cost of revenue, 19% in R&D, 39% in sales and marketing and 16% in G&A period over period, plus a $3,424K right-of-use asset impairment from abandoning headquarters.
Analysis · AMWL · Trade & Services
Cash is the headline here: $180.8 million on hand with no debt, and operating cash burn of just $1.9 million for the first nine months versus $48.6 million a year earlier, which supports management's target of positive operating cash flow in Q4. The 10-Q fills in the numbers behind the same-day earnings release, showing Q3 revenue of $49.0 million fell 13% year over year and the net loss attributable to Amwell widened to $11.4 million from $9.6 million in Q2. The offset is that the top line keeps shrinking — subscription revenue dropped $7.0 million on customer timing and visits fell to 760,000 from 1.09 million — so the improving cash position rests on cost cuts (headcount down 14% to 39% across functions) rather than growth.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AMWL was trading at $13.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $216.7M. The 52-week trading range was $3.71 to $15.16. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.